Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lamivudine MeSH Descriptor Data 2026


MeSH Heading
Lamivudine
Tree Number(s)
D03.383.742.680.245.500.950.500
D13.570.230.329.950.500
D13.570.230.500.925.500
D13.570.685.245.500.950.500
Unique ID
D019259
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D019259
Scope Note
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Entry Term(s)
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
3TC Lamivudine
BCH-189
Epivir
GR-109714X
GR109714X
Lamivudine, (+)-cis-
Lamivudine, (+-)-trans-
Lamivudine, (2S-cis)-Isomer
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
2T8Q726O95
0
134680-32-3
H6S9D88T3D
77ANF82R6X
Related Numbers
134678-17-4
134680-32-3
77ANF82R6X
H6S9D88T3D
Previous Indexing
Cytosine/analogs & derivatives (1991-1992)
Zalcitabine/analogs & derivatives (1993-1996)
Public MeSH Note
97; LAMIVUDINE was indexed under ZALCITABINE/analogs & derivatives 1993-96 and CYTOSINE/analogs & derivatives 1991-92
Online Note
use LAMIVUDINE (NM) to search LAMIVUDINE 1991-96
History Note
97; was LAMIVUDINE (NM) 1991-96
Date Introduced
1997/01/01
Last Updated
2021/10/18
Lamivudine Preferred
BCH-189 Related
Epivir Narrower
Lamivudine, (2S-cis)-Isomer Narrower
GR-109714X Narrower
Lamivudine, (+)-cis- Narrower
Lamivudine, (+-)-trans- Narrower
page delivered in 0.157s